0
Pulmonary Vascular Disease: Pulmonary Vascular Disease II |

Prognostic Relevance of Cardiopulmonary Exercise Testing in the Long-term Follow-up of Scleroderma Patients With and Without PAH

Daniel Dumitrescu, MD; Felix Gerhardt, MD; Thomas Viethen, MD; Stephan Baldus, MD; Pia Moinzadeh, MD; Nicolas Hunzelmann, MD; Stephan Rosenkranz, MD
Author and Funding Information

Herzzentrum der Universitaet zu Koeln, Cologne, Germany


Copyright 2016, American College of Chest Physicians. All Rights Reserved.


Chest. 2016;150(4_S):1184A. doi:10.1016/j.chest.2016.08.1293
Text Size: A A A
Published online

Extract

SESSION TITLE: Pulmonary Vascular Disease II

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM

PURPOSE: Pulmonary arterial hypertension (PAH) is a well-known complication in patients with systemic sclerosis (SSc), harbouring a bad prognosis. While the diagnosis is confirmed by right heart catheterisation (RHC), the initial suspicion of PAH and follow-up measurements rely on non-invasive diagnostic tools. Pathophysiological considerations suggest that cardiopulmonary exercise testing (CPET) may provide clinical information on the mechanism of exercise limitation in SSc patients, and reflect the course of the disease during follow-up. However, the prognostic relevance of exercise gas exchange measurements during follow-up of SSc patients is unclear. We analyzed whether CPET provided relevant prognostic information in the long-term follow up of SSc patients.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543